{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:49:48Z","timestamp":1795038588859,"version":"4.10.2"},"reference-count":37,"publisher":"American Chemical Society (ACS)","issue":"15","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93022C00060"],"award-info":[{"award-number":["75N93022C00060"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019590","name":"Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator","doi-asserted-by":"publisher","award":["4500002736"],"award-info":[{"award-number":["4500002736"]}],"id":[{"id":"10.13039\/100019590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This report summarizes the discovery and optimization of a novel series of nonhydroxamate inhibitors targeting LpxC, a Zn2+-dependent hydrolase that is essential for the survival of Gram-negative bacteria. Beginning with a 5-hydroxypyrimidin-4-one metal-binding pharmacophore, structure-based approaches were utilized to generate a series of potent inhibitors that exhibited activity against a wide variety of Enterobacterales, including both susceptible and multidrug-resistant pathogens, and efficacy in murine thigh infection models. These novel compounds were evaluated in a rat model of cardiovascular toxicity to demonstrate the safety of the scaffold relative to another LpxC inhibitor that proved unsuccessful in Phase I clinical trials. A variety of inhibitors with potent in vivo efficacy and no hemodynamic effects were identified, which constituted an initial suite of potential development candidates.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c01036","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:01:55Z","timestamp":1785873715000},"page":"18692-18704","source":"Crossref","is-referenced-by-count":1,"title":["Discovery and Optimization\nof Novel Nonhydroxamate\nLpxC Inhibitors for the Treatment of Multidrug-Resistant Gram-Negative\nInfections"],"prefix":"10.1021","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6370-7142","authenticated-orcid":true,"given":"David P.","family":"Martin","sequence":"first","affiliation":[{"name":"Blacksmith Medicines, Inc. , , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Teng","sequence":"additional","affiliation":[{"name":"Blacksmith Medicines, Inc. , , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baskar","family":"Nammalwar","sequence":"additional","affiliation":[{"name":"Blacksmith Medicines, Inc. , , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Perez","sequence":"additional","affiliation":[{"name":"Blacksmith Medicines, Inc. , , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Li","sequence":"additional","affiliation":[{"name":"Blacksmith Medicines, Inc. , , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Munguia","sequence":"additional","affiliation":[{"name":"Blacksmith Medicines, Inc. , , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Taganov","sequence":"additional","affiliation":[{"name":"Blacksmith Medicines, Inc. , , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Fan","sequence":"additional","affiliation":[{"name":"Blacksmith Medicines, Inc. , , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Agarwalla","sequence":"additional","affiliation":[{"name":"Blacksmith Medicines, Inc. , , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lonergan","sequence":"additional","affiliation":[{"name":"Blacksmith Medicines, Inc. , , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Tomaras","sequence":"additional","affiliation":[{"name":"Blacksmith Medicines, Inc. , , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Zimmerman","sequence":"additional","affiliation":[{"name":"Blacksmith Medicines, Inc. , , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Puerta","sequence":"additional","affiliation":[{"name":"Blacksmith Medicines, Inc. , , ,","place":["San Diego, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"issue":"10325","key":"2026081311090381700_cit1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global Burden of Bacterial\nAntimicrobial Resistance in 2019: A Systematic Analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"2026081311090381700_cit2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, Research, and Development of New Antibiotics:\nThe WHO Priority List of Antibiotic-Resistant Bacteria and Tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"issue":"10459","key":"2026081311090381700_cit3","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global Burden of Bacterial Antimicrobial Resistance\n1990\u20132021: A Systematic Analysis with Forecasts to 2050","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators.","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"2026081311090381700_cit4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s40265-024-02137-x","article-title":"Antibacterials\nwith Novel Chemical Scaffolds in Clinical Development","volume":"85","author":"Heimann","year":"2025","journal-title":"Drugs"},{"issue":"1","key":"2026081311090381700_cit5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1128\/CMR.00030-10","article-title":"Challenges\nof Antibacterial Discovery","volume":"24","author":"Silver","year":"2011","journal-title":"Clin. Microbiol.\nRev."},{"issue":"5289","key":"2026081311090381700_cit6","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1126\/science.274.5289.980","article-title":"Antibacterial\nAgents That Inhibit\nLipid A Biosynthesis","volume":"274","author":"Onishi","year":"1996","journal-title":"Sci."},{"issue":"15","key":"2026081311090381700_cit7","doi-asserted-by":"publisher","first-page":"11002","DOI":"10.1074\/jbc.275.15.11002","article-title":"Antibacterial\nAgents That Target Lipid A Biosynthesis in Gram-Negative Bacteria","volume":"275","author":"Jackman","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"2026081311090381700_cit8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.chembiol.2010.11.011","article-title":"Species-Specific and\nInhibitor-Dependent Conformations of LpxC: Implications for Antibiotic\nDesign","volume":"18","author":"Lee","year":"2011","journal-title":"Chem. Biol."},{"issue":"14","key":"2026081311090381700_cit9","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1021\/jm010579r","article-title":"Potent, Novel in Vitro Inhibitors\nof the Pseudomonas a Eruginosa Deacetylase LpxC","volume":"45","author":"Kline","year":"2002","journal-title":"J. Med. Chem."},{"issue":"6","key":"2026081311090381700_cit10","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1128\/AAC.46.6.1793-1799.2002","article-title":"Antibacterial Activities\nand Characterization of Novel Inhibitors of LpxC","volume":"46","author":"Clements","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"2026081311090381700_cit11","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1021\/acs.accounts.0c00880","article-title":"Structure- and Ligand-Dynamics-Based\nDesign of Novel Antibiotics\nTargeting Lipid A Enzymes LpxC and LpxH in Gram-Negative Bacteria","volume":"54","author":"Zhou","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"2026081311090381700_cit12","doi-asserted-by":"publisher","first-page":"1541379","DOI":"10.3389\/fmicb.2025.1541379","article-title":"Recent Advances in\nSmall Molecule\nLpxC Inhibitors against Gram-Negative Bacteria (2014\u20132024)","volume":"16","author":"Ji","year":"2025","journal-title":"Front. Microbiol."},{"issue":"11","key":"2026081311090381700_cit13","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1080\/13543776.2017.1360282","article-title":"LpxC Inhibitors: A\nPatent Review (2010\u20132016)","volume":"27","author":"Kalinin","year":"2017","journal-title":"Expert Opin.\nTher. Pat."},{"issue":"2","key":"2026081311090381700_cit14","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1021\/acs.chemrev.8b00201","article-title":"Targeting Metalloenzymes for Therapeutic Intervention","volume":"119","author":"Chen","year":"2019","journal-title":"Chem. Rev."},{"issue":"1","key":"2026081311090381700_cit15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/cmdc.201500486","article-title":"Why Hydroxamates May Not Be the Best\nHistone Deacetylase\nInhibitors\u2500What Some May Have Forgotten or Would Rather Forget?","volume":"11","author":"Shen","year":"2016","journal-title":"ChemMedChem"},{"issue":"16","key":"2026081311090381700_cit16","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/cmdc.201900287","article-title":"Optimization of LpxC Inhibitors for Antibacterial Activity\nand Cardiovascular Safety","volume":"14","author":"Cohen","year":"2019","journal-title":"ChemMedChem"},{"issue":"1","key":"2026081311090381700_cit17","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01295-24","article-title":"Evaluation of a Potent\nLpxC Inhibitor\nfor Post-Exposure Prophylaxis Treatment of Antibiotic-Resistant Burkholderia Pseudomallei in a Murine Infection Model","volume":"69","author":"Heine","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"issue":"708","key":"2026081311090381700_cit18","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf5668","article-title":"Preclinical Safety and Efficacy Characterization of an LpxC Inhibitor\nagainst Gram-Negative Pathogens","volume":"15","author":"Zhao","year":"2023","journal-title":"Sci. Transl.\nMed."},{"issue":"3","key":"2026081311090381700_cit19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1517\/13543776.15.3.253","article-title":"Recent Non-Hydroxamate Matrix Metalloproteinase\nInhibitors","volume":"15","author":"Breuer","year":"2005","journal-title":"Expert Opin. Ther. Pat."},{"issue":"3","key":"2026081311090381700_cit20","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00828-22","article-title":"TP0586532, a Novel Non-Hydroxamate\nLpxC Inhibitor:\nPotentiating Effect on In Vitro Activity of Meropenem\nagainst Carbapenem-Resistant Enterobacteriaceae","volume":"10","author":"Yoshida","year":"2022","journal-title":"Microbiol. Spectrum"},{"key":"2026081311090381700_cit21","doi-asserted-by":"publisher","first-page":"115964","DOI":"10.1016\/j.bmc.2020.115964","article-title":"Lead Optimization of 2-Hydroxymethyl Imidazoles as\nNon-Hydroxamate LpxC Inhibitors: Discovery of TP0586532","volume":"30","author":"Ushiyama","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"2026081311090381700_cit22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jiac.2022.01.004","article-title":"Pharmacodynamic Target\nAssessment and Prediction of Clinically Effective Dosing Regimen of\nTP0586532, a Novel Non-Hydroxamate LpxC Inhibitor, Using a Murine\nLung Infection Model","volume":"28","author":"Fujita","year":"2022","journal-title":"J. Infect. Chemother."},{"issue":"3","key":"2026081311090381700_cit23","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1021\/acs.chemrestox.0c00439","article-title":"Metabolism and Toxicity\nof Fluorine Compounds","volume":"34","author":"Kyzer","year":"2021","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"2026081311090381700_cit24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1021\/cb400067g","article-title":"Structural\nBasis of the Promiscuous\nInhibitor Susceptibility of Escherichia Coli LpxC","volume":"9","author":"Lee","year":"2014","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"2026081311090381700_cit25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/d41573-020-00185-y","article-title":"Improving\nData Sharing to Increase the Efficiency of Antibiotic R&D","volume":"20","author":"Kim","year":"2021","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"4","key":"2026081311090381700_cit26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1107\/S0907444911007773","article-title":"Data Processing\nand\nAnalysis with the autoPROC Toolbox","volume":"67","author":"Vonrhein","year":"2011","journal-title":"Acta Crystallogr., Sect. D:Biol. Crystallogr."},{"issue":"2","key":"2026081311090381700_cit27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr.,\nSect. D:Biol. Crystallogr."},{"issue":"1","key":"2026081311090381700_cit28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1107\/S0907444905036693","article-title":"Scaling and\nAssessment of Data Quality","volume":"62","author":"Evans","year":"2006","journal-title":"Acta Crystallogr.,\nSect. D:Biol. Crystallogr."},{"issue":"7","key":"2026081311090381700_cit29","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How Good Are My Data and What Is\nthe Resolution?","volume":"69","author":"Evans","year":"2013","journal-title":"Acta Crystallogr., Sect. D:Biol.\nCrystallogr."},{"issue":"4","key":"2026081311090381700_cit30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview\nof the CCP 4 Suite and Current Developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr., Sect. D:Biol. Crystallogr."},{"key":"2026081311090381700_cit31","unstructured":"Tickle, I. J.; Flensburg, C.; Keller, P.; Paciorek, W.; Sharff, A.; Vonrhein, C.; Bricogne, G.\n          STARANISO, 2018."},{"issue":"4","key":"2026081311090381700_cit32","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser Crystallographic Software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"2026081311090381700_cit33","unstructured":"Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Sharff, A.; Smart, O. S.; Vonrhein, C.; Womack, T. O.\n          BUSTER, 2017."},{"issue":"4","key":"2026081311090381700_cit34","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and Development\nof Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr.,\nSect. D:Biol. Crystallogr."},{"key":"2026081311090381700_cit35","unstructured":"Smart, O. S.; Sharff, A.; Holstein, J.; Womack, T. O.; Flensburg, C.; Keller, P.; Paciorek, W.; Vonrhein, C.; Bricogne, G.\n          GRADE2."},{"issue":"3","key":"2026081311090381700_cit36","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of Macromolecular\nStructures\nby the Maximum-Likelihood Method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr.,\nSect. D:Biol. Crystallogr."},{"issue":"12","key":"2026081311090381700_cit37","doi-asserted-by":"publisher","first-page":"e00213","DOI":"10.1128\/JCM.00213-21","article-title":"Overview\nof Changes\nto the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100,\n31st Edition","volume":"59","author":"Humphries","year":"2021","journal-title":"J. Clin. Microbiol."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c01036","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/15\/18692\/66392856\/acs.jmedchem.6c01036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/15\/18692\/66392856\/acs.jmedchem.6c01036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:15:54Z","timestamp":1786634154000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/15\/18692\/5243609\/Discovery-and-Optimization-of-Novel-Nonhydroxamate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":37,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8,4]]},"published-print":{"date-parts":[[2026,8,13]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01036","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01036.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01036.s002","asserted-by":"subject"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}